Trials / Unknown
UnknownNCT05869305
Efficacy and Safety of Protein Product in Volunteers With Sarcopenia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study are to evaluate efficacy and safety of protein product in volunteers with sarcopenia.
Detailed description
There are 45 patients in this study. They are randomly divided into 3 groups which are whey protein isolate group, isolated soy protein group, placebo group. They will take the sample 1 sachet/day for 12 weeks. Muscle strength, muscle mass, physical performance, sarcopenia score, body weight, body mass index, protein, immunoglobulins, quality of life, liver function, kidney function, other laboratory value, and adverse effects are evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | whey protein isolate | Take 1 sachet/day for 12 weeks. |
| DIETARY_SUPPLEMENT | isolated soy protein | Take 1 sachet/day for 12 weeks. |
| DIETARY_SUPPLEMENT | placebo | Take 1 sachet/day for 12 weeks. |
Timeline
- Start date
- 2023-06-01
- Primary completion
- 2024-02-01
- Completion
- 2024-03-20
- First posted
- 2023-05-22
- Last updated
- 2023-05-24
Source: ClinicalTrials.gov record NCT05869305. Inclusion in this directory is not an endorsement.